The Jan 1st issue of GEN (pp 16-17) reports on a Kalorama Information market projection on the prospects for the human vaccine market in Europe from 2010-2014. Kalorama predicts the Euro market for vaccines will hit $7.9 B when 2010 is totalled - up from $4 B in 2006. They are further projecting a 10.6% CAGR from 2010-2014 whereupon the market will reach $11.9 B in size.
Growth is driven by both pediatric vaccines (9.6%) and adult vaccines, like H1N1, (11.6%) to produce the projected combined rate of 10.6%. As can be seen, the adult vaccine segment is expected to grow somewhat faster and will move from being 42.8% of the total market in 2010 to 44.8% of the total in 2014.
Five main countries account for the vast majority of the $7.9 B vaccine sales in European - that being Germany ($2.7 B), France, UK, Italy and Spain. The European market is supplied by five main companies: GSK, Sanofi Pasteur MSD, Novartis, Sanofi Pasteur, and Crucell. According to the article, these five account for a combined 82% market share in Europe.
Posted by Bruce Lehr Jan 22nd 2011.
Comments